Cytoplasm
Disorders of the Skeletal Muscle
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 11, 2026

Automated Image-Based Quantification of Neutrophil Extracellular Traps Using NETQUANT
Published on: November 27, 2019
H Nunoi1, T Yamazaki, S Kanegasaki
1Department of Pediatrics, Miyazaki Medical College, Japan.
Neutrophils are immune cells that rely on cytoskeletal changes to move and fight infections. When proteins like actin or its regulators are defective, neutrophils may struggle to function properly. This can lead to diseases where immune responses are impaired. Recent studies have identified specific conditions, such as abnormal-beta-actin disease and Rac 2 mutations, that affect neutrophil movement. These diseases are systemic, meaning they affect the whole body, but the immune dysfunction is particularly noticeable. Researchers reviewed the literature to understand how cytoskeletal defects translate into immune problems. They found that actin dysfunction and abnormal proteins like 47- and 89-kd are linked to chemotactic and motility issues in neutrophils. The findings suggest that more such diseases may be discovered in the future.
14:05Morphological and Compositional Analysis of Neutrophil Extracellular Traps Induced by Microbial and Chemical Stimuli
Published on: November 4, 2022
11:32Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists
Published on: October 18, 2024
Area of Science:
Background:
Neutrophils are essential for immune defense, relying on cytoskeletal reorganization to perform motility and chemotaxis. Prior research has shown that actin polymerization and regulation by associated proteins are crucial for these functions. However, a knowledge gap remains in understanding how cytoskeletal defects lead to specific immune impairments. No prior work had resolved the full spectrum of diseases linked to actin dysfunction in neutrophils. This gap motivated researchers to investigate the molecular basis of such disorders. Abnormalities in actin or its regulatory proteins may manifest as systemic diseases with neutrophil dysfunction. The uncertainty around the mechanisms of these diseases drove a literature review to synthesize current findings. This paper's contribution is to clarify the connection between cytoskeletal defects and immune system impairments.
Purpose Of The Study:
The study aimed to analyze the relationship between cytoskeletal abnormalities in neutrophils and immune dysfunction. Specifically, the researchers sought to identify diseases caused by actin or actin-associated protein defects. They focused on how these defects affect neutrophil motility and chemotaxis. The motivation was to better understand the molecular underpinnings of these disorders. By reviewing existing literature, they aimed to highlight known cases and potential future discoveries. The problem addressed is the lack of clarity on how cytoskeletal changes translate to clinical symptoms. The authors sought to clarify the systemic impact of neutrophil dysfunction. Their goal was to provide a foundation for future research on related diseases.
Main Methods:
The researchers conducted a literature review to synthesize findings on neutrophil cytoskeletal diseases. They analyzed reports of actin dysfunction and associated protein abnormalities. The approach involved examining molecular-level studies of systemic diseases. They focused on cases involving abnormal beta-actin and Rac 2 mutations. The literature was selected based on relevance to cytoskeletal reorganization in neutrophils. The review included studies where chemotactic dysfunction was a key feature. The researchers compared findings across different disease models. Their methods emphasized identifying gaps in current understanding of these disorders.
Main Results:
The strongest finding is the identification of abnormal-beta-actin disease and Rac 2 mutation-related disorders. These conditions are linked to neutrophil chemotactic dysfunction at the molecular level. The literature review revealed systemic manifestations of these diseases. Actin polymerization defects were found to impair neutrophil migration and pathogen ingestion. The presence of abnormal 47- and 89-kd proteins was reported in some cases. These proteins are associated with cytoskeletal reorganization in neutrophils. The study confirmed that cytoskeletal abnormalities can lead to immune system impairments. The findings suggest a need for further research on related actin dysfunction disorders.
Conclusions:
The authors synthesize evidence that cytoskeletal abnormalities in neutrophils lead to immune dysfunction. They emphasize the role of actin and associated proteins in motility and chemotaxis. The review highlights the systemic nature of these diseases despite localized neutrophil defects. The findings suggest that molecular-level studies are critical for understanding these disorders. The authors propose that more diseases with actin dysfunction will be identified in the future. They caution that current knowledge remains incomplete regarding the mechanisms involved. The synthesis suggests a need for targeted research on actin-associated proteins. The implications point to the importance of cytoskeletal integrity in immune cell function.
The core mechanism involves actin polymerization defects, which impair neutrophil motility and chemotaxis, as reported in diseases like abnormal-beta-actin disease.
These proteins are associated with cytoskeletal reorganization, and their dysfunction disrupts neutrophil migration and pathogen ingestion.
Chemotactic dysfunction is a key feature because it reflects impaired actin regulation, which is essential for neutrophil movement toward infection sites.
Beta-actin dysfunction directly affects cytoskeletal reorganization, leading to systemic immune impairments in patients with abnormal-beta-actin disease.
Rac 2 mutations disrupt actin dynamics, contributing to chemotactic dysfunction in neutrophils, as observed in related systemic diseases.
The authors propose that more diseases with actin or actin-associated protein dysfunction may be identified in the near future.